Document is current
Any future updates will be listed below
-
Authors
Wilmes, Anna T.
Reinehr, Sabrina
Kühn, Sandra
Pedreiturria, Xiomara
Petrikowski, Laura
Faissner, Simon
Ayzenberg, Ilya
Stute, Gesa
Gold, Ralf
Dick, H. Burkhard
Kleiter, Ingo
Joachim, Stephanie C.
- License Information
-
More Information
Article History
Received: 27 July 2017
Accepted: 20 May 2018
First Online: 14 June 2018
Ethics approval and consent to participate
: Not applicable.
: SF received travel grants from Biogen Idec and Genzyme, none related to this manuscript.RG serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd., Biogen Idec, Bayer Schering Pharma, and Novartis; has received speaker honoraria from Biogen Idec, Teva Pharmaceutical Industries Ltd., Bayer Schering Pharma, and Novartis; serves as an editor for Therapeutic Advances in Neurological Diseases and on the editorial boards of Experimental Neurology and the Journal of Neuroimmunology; and receives research support from Teva Pharmaceutical Industries Ltd., Biogen Idec, Bayer Schering Pharma, Genzyme, Merck Serono, and Novartis, which are not related to this manuscript.IK received honoraria for consultancy or speaking and travel reimbursement from Bayer Healthcare, Chugai, Merck, Roche, and Shire and grant support from Affectis, Biogen, Chugai and Diamed, all not related to this manuscript. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
